Apimeds Pharmaceuticals US, Inc.
Drug Manufacturers - Specialty & Generic • Healthcare • Matawan, NJ, United States • APUS (ASE)
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras Al Khaimah, the United Arab Emirates.
Stock Performance (90 Days)
Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).
Layoff History
No layoff events recorded for this company.
Recent News
Apimeds Pharmaceuticals Reshapes Board After Director Removal - TipRanks
TipRanks • Jan 2
Apimeds Pharmaceuticals (APUS) activates 1,000 Bitcoin treasury after $100 million PIPE - Stock Titan
Stock Titan • Dec 10
Apimeds Pharmaceuticals closes $100 million PIPE financing - Investing.com
Investing.com • Dec 10
Apimeds Pharmaceuticals US, Inc. Completes Initial Public Offering, Raising $13.5 Million for Clinical Development - Nasdaq
Nasdaq • May 12
APUS IPO News - Inflammation biotech Apimeds Pharmaceuticals ups deal size by 74% ahead of $20 million IPO - renaissancecapital.com
renaissancecapital.com • Jan 29
Other Drug Manufacturers - Specialty & Generic Companies
View All →
Frequently Asked Questions
Has Apimeds Pharmaceuticals US, Inc. had layoffs?
No layoff events have been recorded for Apimeds Pharmaceuticals US, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Apimeds Pharmaceuticals US, Inc. have?
Apimeds Pharmaceuticals US, Inc. has approximately 2 employees.
What industry is Apimeds Pharmaceuticals US, Inc. in?
Apimeds Pharmaceuticals US, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Apimeds Pharmaceuticals US, Inc. a publicly traded company?
Yes, Apimeds Pharmaceuticals US, Inc. is publicly traded under the ticker symbol APUS on the ASE. The company has a market capitalization of approximately $0.02 billion.
Where is Apimeds Pharmaceuticals US, Inc. headquartered?
Apimeds Pharmaceuticals US, Inc. is headquartered in Matawan, NJ, United States at B4-204A5, Business Centre 04, United Arab Emirates.
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.